arrow
Y

Yoshio Tokumoto

ehime university
H指数:27
被引数:2,624

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trends in the Proportion of Hepatitis C Virus Antibody-Positive Patients Who Could be Considered for Direct-Acting Antiviral Therapy Identified Through Preoperative Testing for Ophthalmic Surgery: A Nationwide Multicenter Real-World Cohort Study in Japan

通过眼科手术术前检测识别出的丙型肝炎病毒抗体阳性患者中可考虑直接抗病毒治疗的患者的比例趋势:一项日本全国多中心真实世界队列研究

2026-09-160
OAAI
Reply to “Did the COVID-19 pandemic disrupt the continuity of post-SVR surveillance in HCV-cured patients?”

回复“COVID-19大流行是否中断了HCV治愈患者的SVR后随访的连续性?”

2026-09-020
PRE
Predictors of long-term changes in mALBI grade in cirrhotic patients after sustained virological response with direct-acting antiviral treatment

直接抗病毒治疗后肝硬化患者mALBI分级长期变化的预测因素

2026-08-250
OAAI
Sequential metabolic cascade from normal liver to multimorbidity in lean Asian adults: Multistate progression modelling

从正常肝脏到亚洲瘦型多病态的顺序代谢级联:多状态进展建模

2026-07-011
PRE
Fibrosis-4 Index as a Robust Long-Term Predictor of Cancers in Metabolic Dysfunction-Associated Steatotic Liver Disease

代谢功能障碍相关脂肪性肝病的纤维化-4指数作为癌症的强有力长期预测因子

2026-03-011
PRE
Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in Japan

肝病患者就业状况:一项在日本进行的国家问卷调查

2025-10-040
OAAI
GPAM upregulation enhances hepatic fat deposition and reduces visceral adipose tissue in response to trans-fatty acids

GPAM上调增强了肝脏脂肪沉积,并减少了内脏脂肪组织对反式脂肪酸的响应。

2025-10-040
PRE
Development of a Neural Network to Detect Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease

Hirooka M,Miyake T,Yano R,Nakamura Y,Okazaki Y,Shimamoto T,等. 开发一种用于检测代谢功能障碍相关脂肪性肝病中肝脂肪变性的神经网络。Gastro Hep Adv. (2025) 5:100765. doi: 10.1016/j.gastha.2025.100765

2025-10-011
OAAI
Early alterations in nutritional indices in metabolic dysfunction-associated steatotic liver disease-related cirrhosis

代谢功能障碍相关脂肪性肝病相关肝硬化的早期营养指标变化

2025-07-160
PRE
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy
2024-11-150
PRE
Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology
2024-08-280
OA
Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease
2024-05-312
OAAI
Combined effect of histological findings and diabetes mellitus on liver-related events in patients with metabolic dysfunction-associated steatotic liver disease

组织学检查结果和糖尿病对代谢功能障碍相关脂肪性肝病患者肝脏相关事件的联合影响

2024-04-241
PRE